Cancer Research UK

Tweet this page
<
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
>
Registration as it was on 06 Feb 2023
How to read and use this data card.
Download this datacard

Overview

Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.

Lobbying Costs

None declared

Financial year: Apr 2021 - Mar 2022

Lobbyists (Full time equivalent)

0.75 Fte (1)

Lobbyists with EP accreditation

0

High-level Commission meetings

2

Lobbying Costs over the years

  • Info

    Cancer Research UK   (CRUK)

    EU Transparency Register

    54970512687-47 First registered on 01 Dec 2009

    Goals / Remit

    Cancer Research UK is the largest independent funder of cancer research in the world. https://www.cancerresearchuk.org/sites/default/files/annualreports21-22.pdf In 2021/22, we committed £471m of our income towards our charitable activities. We committed £443m towards cancer research projects that will run for up to five years. We spent £28m on information and influencing work.
    Our world-class research network provides the foundations for our more than 4,000 scientists, doctors and nurses to collaborate across many different research sites, carrying out everything from laboratory studies to large-scale clinical trials. Through programmes like Cancer Grand Challenges, we bring together a worldwide network of leading scientists from across the globe to carry out ground-breaking research.
    We also work with other research funders, cancer societies and governments around the world to pool our resources and knowledge to accelerate progress towards beating cancer.

    Main EU files targeted

    UK-EU relations, UK Data Adequacy, Clinical Trial Regulation, Horizon Europe, tobacco control and other public health potentially including obesity in future; potentially the Orphan & Paediatric Medicines Regulations and the Pharmaceutical Regulation

    Address

    Head Office
    2 Redman Place
    London E20 1JQ
    UNITED KINGDOM
    EU Office
    2 Redman Place
    London E20 1JQ
    UNITED KINGDOM

    Website

  • People

    Total lobbyists declared

    1

    Employment timeLobbyists
    75%1

    Lobbyists (Full time equivalent)

    0.75

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    0 accreditations were / are live (in bold) for the selected state of 28 Sep 2023

    Name Start date End Date
    Mr Mark HEFFERNAN 20 Sep 2019 19 Sep 2020
    Ms Catherine CASTLEDINE 08 Aug 2015 06 Aug 2016
    Mr Andrew Hollingsworth 04 Jul 2013 02 Jul 2014

    Complementary Information

    0.8 Full-time equivalent in the Europe & Global Affairs Manager role. Some policy development support. Occasional involvement by other staff across the organisation.

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Non-governmental organisations, platforms and networks and similar

  • Networking

    Affiliation

    We are member of a number of associations including the European Organisation for Research and Treatment of Cancer (EORTC), Cancer Prevention Europe (CPE - led by IARC) European Public Health Alliance (EPHA), the Smoke Free Partnership (SFP), the Union for International Cancer Control (UICC), International Cancer Research Partnership (ICRP), the Federation of European Academies of Medicine (FEAM), Association of European Cancer Leagues (ECL) and the European Cancer Organisation's (ECO) Health Systems Network.

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Does not represent commercial interests

    Closed financial year

    Apr 2021 - Mar 2022

    Lobbying costs for closed financial year

    Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.

    Total organisational budget in closed year

    748,850,790€

    Major funding types in closed year

    Donations

    Major contributions in closed year

    None declared

    Other financial info

    In 2021/22, we raised a total of £668 million (749 million EUR). We committed £471m of our income towards our charitable activities:

    - We committed £443m towards cancer research projects that will run for up to five years.

    - We spent £28m on information and influencing work

    We also invested £152m in raising funds, including: 

    - £102m raising donated income and managing our investments.

    - £93m running our shops and other trading activity.

    https://www.cancerresearchuk.org/about-us/our-organisation/how-we-spend-your-money

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    Cancer

    Other activities

    Cancer Research UK works with politicians and policy-makers to make sure that cancer stays at the top of the health agenda. We ensure that the views of patients, researchers and health professionals are heard at all levels of government.

    As well as working in Europe, our scientists and researchers advise the Parliaments and Assemblies within the UK on health and scientific policy and charity regulation.

  • Meetings

    Meetings

    2 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't publish information about such meetings. All information below comes from European Commission web pages.

    • Date 03 Mar 2020 Location Brussels
      Subject Horizon Europe - Mission on Cancer
      Cabinet Cabinet of Commissioner Mariya Gabriel
      Portfolio Innovation and Youth
      Attending
      • Maria Koleva (Cabinet member)
    • Date 07 Mar 2018 Location Brussels
      Subject Impact of Brexit on cancer research
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Annika Nowak (Cabinet member)
Download this datacard